ABBOTT LABORATORIES — Director's Dealing 2010

Nov 2, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2010-10-29

Reporting Person: Landgraf John C (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-10-29	Common shares without par value	M	10640	$49.1939	Acquired	86409	Direct
2010-10-29	Common shares without par value	F	10322	$51.75	Disposed	76087	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-10-29	Option (right to buy)	$49.1939	M	10640	Disposed	2010-10-31	Common shares (10640)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	16818	Indirect
Common shares without par value	1606	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of November 1, 2010.

F2: Includes shares acquired under the Abbott Laboratories Dividend Re-investment and Stock Purchase Plan in transactions exempt from Section 16 under Rule 16(a)-11.

F3: The reporting person disclaims beneficial ownership of all securities held by his son.

F4: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.